Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

FDA clears Advair follow up Breo for asthma

But respiratory drug given the thumbs up for adults only

- PMLiVE

Ariad founder Harvey Berger to retire as CEO and chairman

Effective from December 31 or upon finding of successor

Webinar recording: The storytelling method that works for e-detailing

If you can involve healthcare professionals in a story, they will be more open to your arguments.

Anthill Agency

- PMLiVE

New-look Directory from PMGroup launches

Fresh design and updated content shapes the publication’s evolution

- PMLiVE

Prostate cancer treatment market to treble to £8.2bn by 2023

But GlobalData predict growth could be hampered by patent loss for Zytiga

- PMLiVE

Eylea growth closes the gap with Lucentis

Bayer/Regeneron’s drug eye disease drug set for blockbuster status

- PMLiVE

GSK found UK’s drug pricing changes a tough sell

Firm's chief executive met with the government to question the last PPRS update

- PMLiVE

Kythera bags FDA approval for double chin therapy

Comes as cosmetics industry sees major growth

- PMLiVE

Harvoni sales rocket in first quarter

Gilead’s new hepatitis C pill generates stellar revenue

- PMLiVE

Good Relations appoints Louise Veale to consumer health team

She joins as an associate director and will report to Kelly Blaney

- PMLiVE

FDA panel backs Amgen’s T-Vec for melanoma

Approved by a panel of 22 to one despite questions on its impact on survival

Sanofi reception

Poor Lantus sales sees Sanofi’s diabetes unit fall

French firm hit by insulin pricing pressures and soon faces biosimilar threat

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links